Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study)

References

• Baum MK, Jayaweera DT, Duan R, et al. Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami. J Addict Dis 2008;27(2):37-48
   PubMed Web of Science ®Google Scholar
• Gillis J, Cooper C, Rourke S, et al. Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals. Qual Life Res 2012;22(7):1525-35
   PubMed Web of Science ®Google Scholar
• Tsui JI, Bangsberg DR, Ragland K, et al. The impact of chronic hepatitis C on health-related quality of life in homeless and marginally housed individuals with HIV. AIDS Behav 2007;11(4):603-10
   PubMed Web of Science ®Google Scholar
• Protopopescu C, Marcellin F, Spire B, et al. Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8). Qual Life Res 2007;16(4):577-91
   PubMed Web of Science ®Google Scholar
• Préau M, Marcellin F, Carrieri MP, et al. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study. AIDS 2007;21(Suppl 1):S19-27
   PubMed Web of Science ®Google Scholar
• Tillmann HL, Kaiser T, Claes C, et al. Differential influence of different hepatitis viruses on quality of life in HIV positive patients. Eur J Med Res 2006;11(9):381-5
   PubMed Web of Science ®Google Scholar
• Braitstein P, Montessori V, Chan K, et al. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort. AIDS Care 2005;17(4):505-15
   PubMed Web of Science ®Google Scholar
• Forton DM, Allsop JM, Cox IJ, et al. A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS 2005;19(Suppl 3):S53-63
   PubMed Web of Science ®Google Scholar
• Mandorfer M, Payer BA, Scheiner B, et al. Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin. Liver Int 2013;34(1):69-77
   PubMed Web of Science ®Google Scholar
• Marcellin F, Preau M, Dellamonica P, et al. Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects. J Pain Symptom Manage 2007;34(4):413-21
   PubMed Web of Science ®Google Scholar
• Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002;36(5 Suppl 1):S237-44
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Stepanova M, Nader F, et al. Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens. Hepatol 2014;59(6):2161-9
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Stepanova M, Henry L, et al. Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C). J Hepatol 2014;60(4):741-7
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Stepanova M, Zeuzem S, et al. Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE study. J Hepatol 2014;61(2):228-34
   PubMed Web of Science ®Google Scholar
• Marcellin P, Chousterman M, Fontanges T, et al. Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study. Liver Int 2011;31(4):516-24
   PubMed Web of Science ®Google Scholar
• Kemmer N, Hua L, Andersen JW, et al. Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study. J Viral Hepat 2012;19(11):792-800
   PubMed Web of Science ®Google Scholar
• Thein HH, Maruff P, Krahn MD, et al. Improved cognitive function as a consequence of hepatitis C virus treatment. HIV Med 2007;8(8):520-8
   PubMed Web of Science ®Google Scholar
• Tillmann HL, Wiese M, Braun Y, et al. Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment. J Viral Hepat 2011;18(4):252-61
   PubMed Web of Science ®Google Scholar
• Pockros PJ, Hamzeh FM, Martin P, et al. Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments. Hepatol 2010;52(4):1193-200
   PubMed Web of Science ®Google Scholar
• Di Martino V, Thevenot T, Boyer N, et al. HIV coinfection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis C. AIDS 2002;16(3):441-5
   PubMed Web of Science ®Google Scholar
• Dray-Spira R, Spire B, Lert F, et al. General method of the ANRS-VESPA2 Study. in French. Bull Epidémiologique Hebd 2013(26-27):321-4
   Google Scholar
• Duracinsky M, Lalanne C, Le Coeur S, et al. Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument-specific to HIV disease. J Acquir Immune Defic Syndr 2012;59(5):506-15
   PubMed Web of Science ®Google Scholar
• Duracinsky M, Herrmann S, Berzins B, et al. The development of PROQOL-HIV: an international instrument to assess the health-related quality of life of persons living with HIV/AIDS. J Acquir Immune Defic Syndr 2012;59(5):498-505
   PubMed Web of Science ®Google Scholar
• Duracinsky M, Marcellin F, Lert F, et al. Confirmation of the factor structure of the PROQOL-HIV questionnaire to assess health-related quality of life in PLWHA. 14th European AIDS conference, Brussels, Belgium; 2013
   Google Scholar
• Dray-Spira R, Wilson d’Almeida K, Aubrière C, et al. Etat de santé de la population vivant avec le VIH en France métropolitaine en 2011 et caractéristiques des personnes récemment diagnostiquées. Premiers résultats de l’enquête ANRS-Vespa2. Bull Epidémiologique Hebd 2013(26-27):285-92
   Google Scholar
• Kessler R, Andrews G, Mroczek D, et al. The world health organization composite international diagnostic interview short form (CIDI-SF). Int J Methods Psychiatr Res 1998;7(4):171-85
   Google Scholar
• Morlat P, French HIV Experts Group. Prise en charge médicale des personnes vivant avec le VIH - Recommandations du groupe d’experts rapport 2013. Ministère des affaires sociales et de la Santé, Conseil national du Sida, ANRS
   Google Scholar
• Justice AC, Holmes W, Gifford AL, et al. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol 2001;54(Suppl 1):S77-90
   PubMed Web of Science ®Google Scholar
• Herrmann S, McKinnon E, Hyland NB, et al. HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection. Health Qual Life Outcomes 2013;11:56
   PubMed Web of Science ®Google Scholar
• Marcellin F, Preau M, Ravaux I, et al. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. HIV Clin Trials 2007;8(5):320-7
   PubMed Web of Science ®Google Scholar
• Ozkan M, Corapçioglu A, Balcioglu I, et al. Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. Int J Psychiatry Med 2006;36(3):283-97
   PubMed Web of Science ®Google Scholar
• Lim JK, Cronkite R, Goldstein MK, Cheung RC. The impact of chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of life. J Clin Gastroenterol 2006;40(6):528-34
   PubMed Web of Science ®Google Scholar
• Roux P, Demoulin B, Sogni P, et al. La co-infection par le virus de l’hépatite C chez les personnes infectées par le VIH: données de l’enquête ANRS-Vespa2. Bull Epidémiologique Hebd 2013;314-20
   Google Scholar
• Ware JEJr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473-83
   PubMed Web of Science ®Google Scholar
• Skevington SM, Lotfy M, O’Connell KA. The world health organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004;13(2):299-310
   PubMed Web of Science ®Google Scholar
• Marcellin P, Asselah T. Viral hepatitis: impressive advances but still a long way to eradication of the disease. Liver Int 2014;34(Suppl 1):1-3
   PubMed Web of Science ®Google Scholar
• Fitzmaurice G. Confused by confounding? Nutr 2003;19(2):189-91
   PubMed Web of Science ®Google Scholar
• Aden B, Nosyk B, Wittenberg E, Schackman BR. Health-Related Quality of Life in HIV-Infected and At-Risk Women: the Impact of Illicit Drug Use and Hepatitis C on a Community Preference Weighted Measure. Med Decis Mak 2013;34(6):800-8
   PubMed Web of Science ®Google Scholar
• Salmon-Ceron D, Cohen J, Winnock M, et al. Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients’ beliefs (ANRS CO13 HEPAVIH cohort, France). Bmc Health Serv Res 2012;12:59
   PubMed Web of Science ®Google Scholar
• Schwandt M. Ethnic group differences in health-related quality of life in men who have sex with men in the United States. 19th International AIDS Conference; Abstract no. THPE580
   Google Scholar
• Bichoupan K, Dieterich DT. Hepatitis C in HIV-infected patients: impact of direct-acting antivirals. Drugs 2014;74(9):951-61
   PubMed Web of Science ®Google Scholar